Cytokine profile depending on titers of anti-SARS-CoV-2 IgG in the blood plasma of healthy volunteers

Submitted: February 14, 2023
Accepted: November 29, 2023
Published: December 18, 2023
Abstract Views: 1007
PDF: 173
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Post-COVID-19 conditions are the subject of extensive scientific study. It is known that system disorders may persist in people who recover from COVID-19 for 3 to 12 months (in most cases). The first line of systemic disorders is dysfunction of the immune system, especially the cytokine profile. The mechanism of the launch of immune complications is currently unknown. We hypothesized that anti-SARS-CoV-2 IgG might trigger the development of post-COVID-19 complications. Our research aimed to study the cytokine profile (including IL-1β, IL-4, IL-6, IL-8, IL- 10, IL-12β, TNF-α, IFN-γ) and the transcription factor NF-kB in the blood plasma of donor groups depending on various titers of anti-SARS-CoV-2 IgG. We determined the qualitative values of the cytokine parameters using ELISA (Enzyme Linked Immunosorbent Assay). We estimated the changes in the cytokine profiles in all donor groups. Differences between donor groups were established for each research parameter. We detected changes in NF-κB levels as a key transcription factor for the expression of inflammatory cytokines. The highest level was found in the donor group with a titer of anti-SARS-CoV-2 IgG 75±5 Index (S/C). We detected some differences between donor groups in the levels of pro-inflammatory cytokines compared to a reference point. IL-1β, IL-6, IL-8, INF-γ, and TNF-α levels changed in most donor groups with titers of anti-SARS-CoV-2 IgG ≥ 10±3 Index (S/C). In addition, we showed that the decrease in anti-inflammatory cytokine IL-4 in donor groups ranged from the titer of anti-SARS-CoV-2 IgG 55±5 Index (S/C) to 85±5 Index (S/C), but these changes for the anti-inflammatory cytokine IL-10 were not detected. We found that the cytokine profile may be affected during post-COVID-19 conditions. The cytokine profiles of the donor groups changed depending on the titers of anti- SARS-CoV-2 IgG. The obtained results testify to the fact that the antibody subpopulation may be a key reason for immune dysfunction, influencing the development of other pathological processes.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Muzamil A, Tahir HM, Ali S, et al. Inflammatory process and role of cytokines in inflammation: An overview. Punjab Univ J Zool 2022;36:235-50. DOI: https://doi.org/10.17582/journal.pujz/2021.36.2.237.252
Moriyama K, Nishida O. Targeting cytokines, pathogen-associated molecular patterns, and damage-associated molecular patterns in sepsis via blood purification. Int J Mol Sci 2021;22:8882. DOI: https://doi.org/10.3390/ijms22168882
Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin 2007;45:27-37. DOI: https://doi.org/10.1097/AIA.0b013e318034194e
Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol 2021;93:250-6. DOI: https://doi.org/10.1002/jmv.26232
Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J 2022;19:92. DOI: https://doi.org/10.1186/s12985-022-01814-1
Zanza C, Romenskaya T, Manetti AC, et al. Cytokine Storm in COVID-19: Immunopathogenesis and Therapy. Medicina (Kaunas) 2022;58:144. DOI: https://doi.org/10.3390/medicina58020144
Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med 2021;27:601-15. DOI: https://doi.org/10.1038/s41591-021-01283-z
Mobasheri L, Nasirpour MH, Masoumi E, et al. SARS-CoV-2 triggering autoimmune diseases. Cytokine 2022;154:155873. DOI: https://doi.org/10.1016/j.cyto.2022.155873
Sharma C, Bayry J. High risk of autoimmune diseases after COVID-19. Nat Rev Rheumatol 2023;19:399-400. DOI: https://doi.org/10.1038/s41584-023-00964-y
Sreelakshmi PR, Tandale BV, Jadhav AV, et al. A scoping review of persistent symptoms after COVID infection at different follow-up periods. Indian J Public Health 2023;67:292-300. DOI: https://doi.org/10.4103/ijph.ijph_1178_22
Crowther JR. The ELISA guidebook. Methods Mol Biol 2000;149:III-IV, 1-413. DOI: https://doi.org/10.1385/1592590497
Macarena FK. Antibody Validation. Materials and Methods 6. 2016. DOI:10.13070/mm.en.6.1540. Available from: https://www.labome.com/method/Antibody-Validation.html
Gudowska-Sawczuk M, Mroczko B. The role of nuclear factor kappa B (NF-κB) in development and treatment of COVID-19: Review. Int J Mol Sci 2022;23:5283. DOI: https://doi.org/10.3390/ijms23095283
Iacobazzi D, Convertini P, Todisco S, et al. New insights into NF-κB signaling in innate immunity: focus on immunometabolic crosstalks. Biology (Basel) 2023;12:776. DOI: https://doi.org/10.3390/biology12060776
Shih VF, Tsui R, Caldwell A, Hoffmann A. A single NFκB system for both canonical and non-canonical signaling. Cell Res 2011;21:86-102. DOI: https://doi.org/10.1038/cr.2010.161
Zhang JY, Whalley JP, Knight JC, et al. SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile. Genome Med 2023;15:69. DOI: https://doi.org/10.1186/s13073-023-01227-x
Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med (Lausanne) 2023;10:1011936. DOI: https://doi.org/10.3389/fmed.2023.1011936
Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 2022;23:210-6. DOI: https://doi.org/10.1038/s41590-021-01113-x
Queiroz MAF, Neves PFMD, Lima SS, et al. Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol 2022;12:922422. DOI: https://doi.org/10.3389/fcimb.2022.922422
Schultheiß C, Willscher E, Paschold L, et al. The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 2022;3:100663. DOI: https://doi.org/10.1016/j.xcrm.2022.100663
Karki R, Sharma BR, Tuladhar S, et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 2021;184:149-68.e17. DOI: https://doi.org/10.1016/j.cell.2020.11.025
Gomes SMR, Brito ACS, Manfro WFP, et al. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients. PLoS One 2023;18:e0283983. DOI: https://doi.org/10.1371/journal.pone.0283983
Taghizadeh-Hesary F, Akbari H. The powerful immune system against powerful COVID-19: A hypothesis. Med Hypotheses 2020;140:109762. DOI: https://doi.org/10.1016/j.mehy.2020.109762
Rachkovska A, Krenytska D, Karbovskyy V, et al. Characteristics of products of fibrinogen origin in the presence of Anti- SARS-CoV-2 IgG in the bloodstream. Rev Recent Clin Trials 2023;18:69-75. DOI: https://doi.org/10.2174/1574887118666221219115856
Katrii T, Shandyuk V, Vovk T, et al. Effect of IgG from multiple sclerosis patients on amidolytic activity of coagulation and anticoagulation factors of hemostasis. BMRAT 2017;4:1502-12. DOI: https://doi.org/10.15419/bmrat.v4i08.205
Houen G, Trier NH. Epstein-Barr virus and systemic autoimmune diseases. Front Immunol 2021;11:587380. DOI: https://doi.org/10.3389/fimmu.2020.587380
Raksha N, Burlova-Vasylieva M, Torgalo E, et al. The appearance of molecules of prothrombin origin in blood upon development of atherothrombotic and cardioembolic ischemic stroke. Bull Taras Shevchenko Nat Univ Kyiv Series: Biol 2014;68:57-60. DOI: https://doi.org/10.17721/1728_2748.2014.68.57-60

How to Cite

Krenytska, D., Rachkovska, A., Karbovskyy, V., Raksha, N., Vovk, T., Savchuk, O., Ostapchenko, L., & Halenova, T. (2023). Cytokine profile depending on titers of anti-SARS-CoV-2 IgG in the blood plasma of healthy volunteers. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 96(2). https://doi.org/10.4081/jbr.2023.11256